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Purpose

Case Study

Juvenile xanthogranulomas (JXG) are a benign histiocytic cell proliferative
disorder in early childhood. They most commonly present within the first two
years of life with papular or nodular changes to the skin on the head, neck or
upper trunk. Xanthogranulomas are mostly self-limiting, can be singular or
multiple, and rarely can infer a systemic disease process1. The purpose of
this study was to publish a unique finding of an extra-tendinous solitary mass
in an otherwise healthy 17-year old, with surgical and medical treatment after
diagnosis.

A healthy 17-year-old male presented to clinic with atraumatic 2nd
metatarsophalangeal joint (MTPJ) pain on his left foot. Physical examination
revealed pain to palpation of the plantar 2nd MTPJ with no callus or
dermatological abnormalities. There was a negative Lachman’s test and no
subluxation of the 2nd MTPJ present. Patient had pain on extension of the
2nd MTPJ but passive and active ROM were WNL. End extension was the
most painful. Plain film radiographs were taken (Figure 1) which did not show
any bony abnormality or signs of predislocation syndrome. Conservative care
with modification of shoegear and orthotics were suggested.

Literature Review

After three months of failed conservative care, the patient returned to clinic
and an MRI revealed a 2nd MTP plantar mass measuring 6mm x 6mm x
4mm, directly plantar lateral to the 2nd MTPJ (Figure 2A,B,C). The mass was
hypointense on T1, T2, PD and PD fat saturated imaging. At this point in time,
the patient electively wanted to undergo soft tissue mass removal. Surgical
intervention was successful and a well circumscribed nodule measuring 1.1 x
0.8 x 0.6 cm was removed.

Juvenile xanthogranulomas are the most common of the non-Langerhans
cell histiocytoses1. In a large tumor registry comprised of over 24,000
juvenile soft tissue masses, the incidence of JXG is approximately 0.5%.
However, this could underrepresent the incidence because some of these
diagnoses were made without histological confirmation2. Histologically JXG
appear with multinucleated giant cells, and spindle cells in the younger
population. In more mature tumors, there is an increased lipid composition
with Touton giant cells. These immunohistochemically stain positive for
Factor XIIIa, CD68, CD163, CD14, and are negative for S1003. Clinically,
the most common appearance of these masses are nodules in
subcutaneous or deep tissue or yellow plaques or papules. Solitary skin
lesions are found in 67-71% of all cases, multiple lesions are seen in 7-10%
of patients with JXGs4.
Treatment is typically performed with excisional biopsy and treatment, most
of these lesions are self-limiting and the majority resolve on their own
through childhood5. Most resolve into hyperpigmented lesions, which are
asymptomatic. Surgical intervention is indicated when conservative care
fails, or the lesions appear malignant in nature. Rarely, these cases have
systemic manifestations, but associated conditions to JXG are
neurofibromatosis type 1 (NF-1) or juvenile myelomonocytic leukemia9,10.
Figure 1.
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Figure 3. (Left) Hematoxylin
and eosin staining with foam
cells

Figure 4. (Right) CD 68 positive
immunohistochemical stained
image of the soft tissue mass

Analysis and Discussion
Although exceedingly rare, the majority of these lesions are self-limiting and
resolve in the pediatric patient population. Two large case series have been
performed for JXG. Dehner’s study of 174 JXG lesions showed that only about
16% of masses were in the lower extremity, and four on the lower leg. With
complete excisional biopsy, there was a 0% recurrence rate4. Janssen and
Harms, in their study of 129 patients with JXG, showed only a 10% incidence
on the lower extremity and only 2 patients with lesions on the sole of their foot.
Their recurrence rate was 7% with total excision of the solitary masses. These
recurrences were in the same surgical site and did not migrate2. More
recently, there are scant case studies of juvenile xanthogranulomas on the
soles of the feet, posterior heel and only one case subcutaneously of the 1st
metatarsophalangeal joint6-8.

Pathological evaluation included hemotoxylin and eosin (H&E) (Figure 3) and
CD68 immunohistochemical staining (Figure 4). After positive CD68 staining
and foam cells seen on H&E staining, the mass was diagnosed as a tuberous
xanthoma. A lipid panel was then ordered for the patient to determine if he
had familial hypercholesteremia. Under the American Heart Association, he
did not have familial hypercholesteremia and was not put on statin therapy
despite an elevated cholesterol level. The pathologic specimen was then sent
to Brigham and Women’s hospital (Boston, MA) and further evaluated. It was
shown to have stained negative for S100, and positive for PU.1 and CD163.
This showed there were bland histiocytes and no signs of malignancy. The
final pathologic diagnosis was determined to be xanthogranuloma with
infarction.

In conclusion, we present a unique soft tissue tumor with a very unique
presentation from the majority of JXG’s in the literature. There was no
dermatological component, the patient was slightly older than the average
patient population, and the patient was relatively normolipidemic. We hope this
adds to the body of literature and urge foot and ankle surgeons to use a
medical team approach if they were to ever encounter one of these rare
tumors.

The patient was followed for one year and postoperatively healed his incision
at three weeks with no signs of infection. Patient progressed to weight
bearing as tolerated and was back to his previous activity level at three
months. There were no complications in his follow up period.
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